Genome-wide characterisation of hepatitis B mutations involved in clinical outcome

article published in 2006

Genome-wide characterisation of hepatitis B mutations involved in clinical outcome is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/SJ.HDY.6800882
P698PubMed publication ID16896341

P50authorRichard NicholsQ27925011
François BallouxQ42874334
P2093author name stringG R Foster
A Manica
A Bartholomeusz
C Szmaragd
P2860cites workMEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignmentQ27860726
Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface proteinQ33717942
High affinity binding site for nuclear factor I next to the hepatitis B virus S gene promoter.Q33880229
Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigenQ34225571
Genetic susceptibility in chronic viral hepatitisQ34416280
Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infectionQ34455697
Genetic variability in hepatitis B virusesQ34656016
Hepatitis B viral genotypes: clinical relevance and molecular characteristics.Q34723072
The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virusQ34942505
Hepatitis viruses: a pandora's box?Q35048255
Hepatitis B virus: significance of genotypesQ36048711
Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapyQ36234130
The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitisQ36364632
Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areasQ36504737
Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factorQ36686383
Can three incongruence tests predict when data should be combined?Q36869855
Intracellular retention of surface protein by a hepatitis B virus mutant that releases virion particlesQ39872988
Recombination in the genesis and evolution of hepatitis B virus genotypesQ40670343
Detection and significance of a G1862T variant of hepatitis B virus in Chinese patients with fulminant hepatitisQ40709991
Full-length genomic analysis of hepatitis B virus isolates in a patient progressing from hepatitis to hepatocellular carcinomaQ40790468
Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.Q41277179
The clinical significance of surface antigen variants of hepatitis B virusQ41428169
Fine specificity of the human T-cell response to the hepatitis B virus preS1 antigenQ41616784
Geography is a better determinant of human genetic differentiation than ethnicityQ42068397
The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivatorQ42631282
Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twinsQ43766274
Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapyQ43910476
Hepatitis B virus core protein mutations are concentrated in B cell epitopes in progressive disease and in T helper cell epitopes during clinical remissionQ45183116
Mutation analysis of hepatitis B virus promoters in chronically infected childrenQ45477738
Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection?Q45585483
A revised evolutionary history of hepatitis B virus (HBV).Q45732403
Hepatitis B virus mutants and fulminant hepatitis B: fitness plus phenotypeQ45736286
Naturally occurring mutations of hepatitis B virus and outcome of chronic infection: is there an association?Q45740559
High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum.Q45743105
Long-term mutation rates in the hepatitis B virus genomeQ45745045
Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection?Q45745551
Genotypic differences in the hepatitis B virus core promoter and precore sequences during seroconversion from HBeAg to anti-HBeQ45745755
Hepatitis B virus genomes from long-term immunosuppressed virus carriers are modified by specific mutations in several regionsQ45746125
Hepatitis B virus core promoter mutations in children with multiple anti-HBe/HBeAg reactivations result in enhanced promoter activityQ45746614
Deletions in the hepatitis B virus core gene may influence the clinical outcome in hepatitis B e antigen-positive asymptomatic healthy carriersQ45752637
Clinical implications of mutations in the hepatitis B virus genomeQ45753505
Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapyQ45755644
Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicityQ45756190
Hepatitis B virus carriers without precore mutations in hepatitis B e antigen-negative stage show more severe liver damageQ45768675
Replication kinetics and cytopathic effect of hepatitis A virusQ45845446
Epitope mapping of the PreS1 domain of the hepatitis B virus large surface proteinQ45860265
Prevalence of HBV core promoter/precore/core mutations in Gambian chronic carriersQ46315303
HBV core sequence: definition of genotype-specific variability and correlation with geographical originQ48166961
Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis BQ57205485
A novel approach to characterise pathogen candidate genetic polymorphisms involved in clinical outcomeQ57765683
The hepatitis B virusQ59051957
The influence of age on the development of the hepatitis B carrier stateQ70476628
Molecular epidemiology and variation of hepatitis B in recent immigrant families to AustraliaQ77075898
Interaction of hepatitis B viral X protein and CCAAT/ enhancer-binding protein alpha synergistically activates the hepatitis B viral enhancer II/pregenomic promoterQ77896896
P433issue6
P407language of work or nameEnglishQ1860
P921main subjecthepatitis BQ6853
P304page(s)389-97
P577publication date2006-12-01
P1433published inHeredityQ2261546
P1476titleGenome-wide characterisation of hepatitis B mutations involved in clinical outcome
P478volume97

Reverse relations

cites work (P2860)
Q92153473Association Between HBx Variations and Development of Severe Liver Disease Among Indonesian Patients
Q40736334Characterization of C69R variant HBsAg: effect on binding to anti-HBs and the structure of virus-like particles.
Q42632231Characterization of hepatitis B virus genome variability in Iranian patients with chronic infection, a nationwide study
Q37376530Decreased antigenicity profiles of immune-escaped and drug-resistant hepatitis B surface antigen (HBsAg) double mutants
Q33594925Hepatitis B virus genetic mutations and evolution in liver diseases
Q54678968Long-term Protection After Hepatitis B Vaccine.
Q43498043Molecular characterization of hepatitis B virus strains circulating in Belgian patients co-infected with HIV and HBV: overt and occult infection
Q41965007Polymorphism rtQ215H in primary resistance to adefovir dipivoxil in hepatitis B virus infection: a case report
Q38114999Renal transplantation from hepatitis B surface antigen (HBsAg)-positive donors to HBsAg-negative recipients: a case of post-transplant fulminant hepatitis associated with an extensively mutated hepatitis B virus strain and review of the current lite
Q42912476Selecting a genetic region for molecular analysis of hepatitis B virus transmission
Q45399142The population genomics of hepatitis B virus

Search more.